Literature DB >> 3729723

The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.

P H Russell.   

Abstract

Monoclonal antibodies (MAbs) to 2 epitopes on the haemagglutinin-neuraminidase (HN) protein of the Ulster strain of Newcastle disease virus neutralized synergistically: MAbs to HN-1 and HN-2 neutralized 1.2 and 1.7 log10 infectious units (i.u.) of virus when single as compared to 4.1 when combined. Although MAb to HN-1 but not to HN-2 inhibited haemagglutination they both neutralized more virus on desialyzed cells compared to normal cells and were considered to have interfered with viral attachments in a cooperative manner when combined. A third MAb to fusion (F) protein reduced infectivity by five log10 i.u. HN-1, HN-2 and F were not the only immunodominant epitopes because mutants, which simultaneously lacked all 3 epitopes, were indistinguishable from wild type when neutralized by polyclonal mouse, rabbit or chicken antiserum to whole virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729723     DOI: 10.1007/bf01314151

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations.

Authors:  R J Avery; J Niven
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

2.  Biological consequences of neuraminidase deficiency in Newcastle disease virus.

Authors:  G W Smith; L E Hightower
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

3.  Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

4.  The characterization of monoclonal antibodies to Newcastle disease virus.

Authors:  P H Russell; P C Griffiths; K K Goswami; D J Alexander; M J Cannon; W C Russell
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

5.  Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants.

Authors:  P H Russell
Journal:  J Gen Virol       Date:  1984-04       Impact factor: 3.891

6.  Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies.

Authors:  P H Russell; D J Alexander
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity.

Authors:  R D Possee; G C Schild; N J Dimmock
Journal:  J Gen Virol       Date:  1982-02       Impact factor: 3.891

8.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

9.  Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons.

Authors:  K Nishikawa; S Isomura; S Suzuki; E Watanabe; M Hamaguchi; T Yoshida; Y Nagai
Journal:  Virology       Date:  1983-10-30       Impact factor: 3.616

10.  Newcastle disease virus and two influenza viruses: differing effects of acid and temperature on the uptake of infectious virus into bovine and canine kidney cell lines.

Authors:  P H Russell
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

View more
  2 in total

1.  Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.

Authors:  F Verrier; A Nádas; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.

Authors:  Ana Chumbe; Ray Izquierdo-Lara; Katherine Calderón; Manolo Fernández-Díaz; Vikram N Vakharia
Journal:  Virol J       Date:  2017-11-23       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.